Instil Bio (TIL) Revenue (2020)
Instil Bio (TIL) posted quarterly Revenue of $52000.0 for Q3 2020, up 23.81% quarter-over-quarter from $42000.0 in Q2 2020.
Instil Bio (TIL) Revenue (2020) Analysis & Trends
Instil Bio's Revenue history runs 1 years deep, the most recent figure standing at $52000.0 for Q3 2020.
- In Q3 2020, Revenue changed N/A year-over-year to $52000.0; the TTM figure through Jun 2021 stood at $52000.0 (changed N/A YoY), while the FY2020 annual figure was $138000.0, changed N/A from the prior year.
- Revenue for Q3 2020 stood at $52000.0, up from $42000.0 in the prior quarter.
- The five-year high for Revenue was $52000.0 in Q3 2020, with the low at $42000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 52,000.00 |
| Jun 30, 2020 | 42,000.00 |
| Mar 31, 2020 | 44,000.00 |